INS and type 2 diabetes mellitus: In this sense, real-world data from an extensive U.S. electronic medical records database, including 6597 subjects, suggested that among patients with T2DM who initiated basal insulin after oral antidiabetic drugs, the likelihood of reaching glycemic control diminished over time and remained low from 12 months onwards [64].